Furthermore, the loss of function assay revealed that knockdown of lncTCF7 significantly inhibited glioma cell migration, proliferation and tumorigenicity through upregulating E-cadherin or suppressing TCF7/Sox2 and CyclinD1 expression. This evidence concerns the gene TCF7 and glioma.